Urocortin 2 peptide long acting (Eli Lilly)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameUrocortin 2 peptide long acting (Eli Lilly)
Drug Alias NameUrocortin-2 peptide agonist long acting - Eli Lilly
ClassificationBiologics
Mechanisms of ActionCorticotropin-releasing factor receptor 1 stimulantsCorticotropin-releasing factor receptor 2 stimulants
TargetsCorticotropin-releasing factor receptor 1Corticotropin-releasing factor receptor 2
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A